Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
EMERYVILLE, Calif. and TOKYO, June 14, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and Takasago International Corporation (TYO:4914), a global leader in...
-
EMERYVILLE, Calif., June 13, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that, on May 29, 2016, Cathay Pacific commenced a two-year...
-
Amyris’s µPharmTM Platform to be Used for Rapid Integrated Discovery and Production of Therapeutic Compounds EMERYVILLE, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the...
-
EMERYVILLE, Calif., May 27, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor...
-
EMERYVILLE, Calif., May 20, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and South Korea-based CJ CheilJedang Corporation (“CJ”)(KRX:097950), today...
-
EMERYVILLE, Calif., May 11, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor...
-
Q1 2016 revenues of $8.8 million, including product sales growth of 50% over Q1 2015Reduced selling, general and administrative expenses by 15% and continued progress in exit from non-strategic...
-
EMERYVILLE, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- Biossance™, the pioneer of sustainable solutions in beauty from Amyris, Inc. (Nasdaq:AMRS), announced today the Blacklist ─ 2,000+ common...
-
EMERYVILLE, Calif., April 29, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2016 after market close on Tuesday, May 10,...
-
EMERYVILLE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has executed a five year Biofene® supply agreement with...